{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T02:58:59Z","timestamp":1778641139104,"version":"3.51.4"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:00:00Z","timestamp":1759795200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:00:00Z","timestamp":1759795200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-11716-6","type":"journal-article","created":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T10:57:08Z","timestamp":1759834628000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The efficacy and effectiveness of COVID-19 vaccines in Iran: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-3618-1451","authenticated-orcid":false,"given":"Seyede Maryam","family":"Mousavi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1124-3311","authenticated-orcid":false,"given":"Sobhan","family":"Younesian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2870-7433","authenticated-orcid":false,"given":"Masud","family":"Yunesian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6438-6833","authenticated-orcid":false,"given":"Akbar","family":"Fotouhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,7]]},"reference":[{"issue":"4","key":"11716_CR1","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00028-20","volume":"33","author":"K Dhama","year":"2020","unstructured":"Dhama K, Khan S, Tiwari R, Sircar S, Bhat S, Malik YS, et al. Coronavirus disease 2019-COVID-19. Clin Microbiol Rev. 2020. https:\/\/doi.org\/10.1128\/CMR.00028-20","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"11716_CR2","first-page":"157","volume":"91","author":"D Cucinotta","year":"2020","unstructured":"Cucinotta D, Vanelli M. WHO declares COVID-19 a pandemic. Acta Biomed. 2020;91(1):157\u201360.","journal-title":"Acta Biomed"},{"key":"11716_CR3","unstructured":"World.Health.Organization. Statement on the fifteenth meeting of the IHR. (2005) Emergency Committee on the COVID-19 pandemic 2023 [Available from: https:\/\/www.who.int\/news\/item\/05-05-2023-statement-on-the-fifteenth-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-coronavirus-disease-(covid-19)-pandemic"},{"issue":"1","key":"11716_CR4","doi-asserted-by":"publisher","first-page":"e122","DOI":"10.15190\/d.2021.1","volume":"9","author":"A Fortner","year":"2021","unstructured":"Fortner A, Schumacher D, First. COVID-19 vaccines receiving the US FDA and EMA emergency use authorization. Discoveries (Craiova). 2021;9(1):e122.","journal-title":"Discoveries (Craiova)"},{"issue":"10269","key":"11716_CR5","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0140-6736(20)32661-1","volume":"397","author":"M Voysey","year":"2021","unstructured":"Voysey M, Clemens SAC, Madhi SA, Weckx LY, Folegatti PM, Aley PK, et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet. 2021;397(10269):99\u2013111.","journal-title":"Lancet"},{"issue":"1","key":"11716_CR6","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1038\/s41598-022-05788-6","volume":"12","author":"C Jeewandara","year":"2022","unstructured":"Jeewandara C, Fernando S, Pushpakumara PD, Ramu ST, Kamaladasa A, Gunasekara B, et al. Immune responses following the first dose of the Sputnik V (Gam-COVID-Vac). Sci Rep. 2022;12(1):1727.","journal-title":"Sci Rep"},{"issue":"1","key":"11716_CR7","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S1473-3099(20)30831-8","volume":"21","author":"S Xia","year":"2021","unstructured":"Xia S, Zhang Y, Wang Y, Wang H, Yang Y, Gao GF, et al. Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1\/2 trial. Lancet Infect Dis. 2021;21(1):39\u201351.","journal-title":"Lancet Infect Dis"},{"issue":"9","key":"11716_CR8","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/S1473-3099(22)00320-6","volume":"22","author":"OJ Watson","year":"2022","unstructured":"Watson OJ, Barnsley G, Toor J, Hogan AB, Winskill P, Ghani AC. Global impact of the first year of COVID-19 vaccination: a mathematical modelling study. Lancet Infect Dis. 2022;22(9):1293\u2013302.","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"11716_CR9","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1038\/s41562-021-01122-8","volume":"5","author":"E Mathieu","year":"2021","unstructured":"Mathieu E, Ritchie H, Ortiz-Ospina E, Roser M, Hasell J, Appel C, et al. A global database of COVID-19 vaccinations. Nat Hum Behav. 2021;5(7):947\u201353.","journal-title":"Nat Hum Behav"},{"key":"11716_CR10","doi-asserted-by":"publisher","first-page":"1087138","DOI":"10.3389\/fpubh.2022.1087138","volume":"10","author":"B Duroseau","year":"2022","unstructured":"Duroseau B, Kipshidze N, Limaye RJ. The impact of delayed access to COVID-19 vaccines in low- and lower-middle-income countries. Front Public Health. 2022;10:1087138.","journal-title":"Front Public Health"},{"issue":"7","key":"11716_CR11","doi-asserted-by":"publisher","first-page":"587","DOI":"10.26719\/emhj.23.040","volume":"29","author":"F Bahmani","year":"2023","unstructured":"Bahmani F, Parsapour A, Abbasi N, Zahraei S, Tavakoli N, Shamsi-Gooshki E. Priority-setting for early access to COVID-19 vaccines in Islamic Republic of Iran. East Mediterr Health J. 2023;29(7):587\u201398.","journal-title":"East Mediterr Health J"},{"key":"11716_CR12","unstructured":"Coronavirus. (COVID-19) Vaccinations Published online at OurWorldinData.org [Internet]. Available from: https:\/\/ourworldindata.org\/covid-vaccinations"},{"key":"11716_CR13","unstructured":"COVID-19 Update Islamic Republic of Iran Weekly Update on COVID-. 19 2023 [Available from: https:\/\/www.emro.who.int\/images\/stories\/iran\/covid-19-sit-reps\/COVID-19-Update-230520.pdf?ua=1"},{"key":"11716_CR14","unstructured":"World Health Organization. 2025 data.who.int, WHO Coronavirus (COVID-19) dashboard\u2009>\u2009Deaths [Dashboard] [Available from: https:\/\/data.who.int\/dashboards\/covid19\/deaths"},{"key":"11716_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2023.1073259","volume":"11","author":"M-M Gouya","year":"2023","unstructured":"Gouya M-M, Seif-Farahi K, Hemmati P. An overview of Iran\u2019s actions in response to the COVID-19 pandemic and in building health system resilience. Front Public Health. 2023. https:\/\/doi.org\/10.3389\/fpubh.2023.1073259","journal-title":"Front Public Health"},{"issue":"1","key":"11716_CR16","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/s41541-023-00773-0","volume":"8","author":"BA Williams","year":"2023","unstructured":"Williams BA, Jones CH, Welch V, True JM. Outlook of pandemic preparedness in a post-COVID-19 world. Npj Vaccines. 2023;8(1):178.","journal-title":"Npj Vaccines"},{"key":"11716_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/ijph.2022.1605094","volume":"67","author":"A Takian","year":"2022","unstructured":"Takian A, Aarabi SS, Semnani F, Rayati Damavandi A. Preparedness for future pandemics: lessons learned from the COVID-19 pandemic in Iran. Int J Public Health. 2022. https:\/\/doi.org\/10.3389\/ijph.2022.1605094","journal-title":"Int J Public Health"},{"issue":"10","key":"11716_CR18","doi-asserted-by":"publisher","first-page":"3310","DOI":"10.1080\/21645515.2021.1945902","volume":"17","author":"J Li","year":"2021","unstructured":"Li J, Chen W, Chen M, Bai S, Yuan Q, Wu J. Immunogenicity of inactivated COVID-19 vaccines at different vaccination intervals. Hum Vaccin Immunother. 2021;17(10):3310\u20133.","journal-title":"Hum Vaccin Immunother"},{"key":"11716_CR19","doi-asserted-by":"publisher","first-page":"i4919","DOI":"10.1136\/bmj.i4919","volume":"355","author":"JA Sterne","year":"2016","unstructured":"Sterne JA, Hern\u00e1n MA, Reeves BC, Savovi\u0107 J, Berkman ND, Viswanathan M, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919.","journal-title":"BMJ"},{"key":"11716_CR20","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JPT Higgins","year":"2011","unstructured":"Higgins JPT, Altman DG, G\u00f8tzsche PC, J\u00fcni P, Moher D, Oxman AD, et al. The Cochrane collaboration\u2019s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.","journal-title":"BMJ"},{"key":"11716_CR21","doi-asserted-by":"crossref","unstructured":"McGuinness LA, Higgins JPT. Risk-of-bias visualization (robvis): an R package and Shiny web app for visualizing risk-of-bias assessments. Res Synthesis Methods. 2020;n\/a(n\/a).","DOI":"10.1002\/jrsm.1411"},{"issue":"6","key":"11716_CR22","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofac177","volume":"9","author":"A Mirahmadizadeh","year":"2022","unstructured":"Mirahmadizadeh A, Heiran A, Bagheri Lankarani K, Serati M, Habibi M, Eilami O, et al. Effectiveness of coronavirus disease 2019 vaccines in preventing infection, hospital admission, and death: a historical cohort study using Iranian registration data during vaccination program. Open Forum Infect Dis. 2022;9(6):ofac177.","journal-title":"Open Forum Infect Dis"},{"key":"11716_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2023.104548","volume":"71","author":"M Barzegar","year":"2023","unstructured":"Barzegar M, Manteghinejad A, Afshari-Safavi A, Mirmosayyeb O, Nasirian M, Bagherieh S, et al. Effectiveness of BBIBP-CorV vaccine in preventing SARS-CoV2 infection and severe outcomes in people living with multiple sclerosis: a population-based study. Mult Scler Relat Disord. 2023;71:104548.","journal-title":"Mult Scler Relat Disord"},{"key":"11716_CR24","doi-asserted-by":"publisher","first-page":"1420651","DOI":"10.3389\/fimmu.2024.1420651","volume":"15","author":"F Khosravi Shadmani","year":"2024","unstructured":"Khosravi Shadmani F, Moradi G, Naghipour M, Torkaman Asadi F, Ahmadi A, Mirahmadizadeh A, et al. Evaluation of the COVID-19 vaccine effectiveness on the outcomes of COVID 19 disease in Iran: a test-negative case-control study. Front Immunol. 2024;15:1420651.","journal-title":"Front Immunol"},{"issue":"1","key":"11716_CR25","first-page":"35","volume":"20","author":"F Zomorrodi Zare","year":"2024","unstructured":"Zomorrodi Zare F, Khosravi Shadmani F, Safari Faramani R, Torkamanasadi F, Rezaei Y, Najafi F. Evaluating the effectiveness of the COVID-19 vaccines on infection indicators and severe outcomes in Hamadan Province (2021\u20132022). Iran J Epidemiol. 2024;20(1):35\u201344.","journal-title":"Iran J Epidemiol"},{"key":"11716_CR26","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.ijid.2022.12.024","volume":"128","author":"A Heidarzadeh","year":"2023","unstructured":"Heidarzadeh A, Amini Moridani M, Khoshmanesh S, Kazemi S, Hajiaghabozorgi M, Karami M. Effectiveness of COVID-19 vaccines on hospitalization and death in Guilan, Iran: a test-negative case-control study. Int J Infect Dis. 2023;128:212\u201322.","journal-title":"Int J Infect Dis"},{"issue":"3","key":"11716_CR27","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1002\/ijgo.15077","volume":"163","author":"N Changizi","year":"2023","unstructured":"Changizi N, Eshrati B, Salehi M, Beheshtian M, Hadipour Jahromy L, Emami Afshar N, et al. Vaccination effects on reducing COVID-19 complications in pregnancy: a large-scale report from Iran. Int J Gynaecol Obstet. 2023;163(3):1012\u20137.","journal-title":"Int J Gynaecol Obstet"},{"issue":"3","key":"11716_CR28","doi-asserted-by":"publisher","first-page":"e28607","DOI":"10.1002\/jmv.28607","volume":"95","author":"H Jamaati","year":"2023","unstructured":"Jamaati H, Karimi S, Ghorbani F, Panahi Y, Hosseini-Baharanchi FS, Hajimoradi M, et al. Effectiveness of different vaccine platforms in reducing mortality and length of ICU stay in severe and critical cases of COVID-19 in the Omicron variant era: A National cohort study in Iran. J Med Virol. 2023;95(3):e28607.","journal-title":"J Med Virol"},{"issue":"8","key":"11716_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines12080906","volume":"12","author":"M Runge","year":"2024","unstructured":"Runge M, Karimian Z, Kheirandish M, Borghi G, Wodniak N, Fahmy K, et al. COVID-19 vaccine effectiveness studies against symptomatic and severe outcomes during the Omicron period in four countries in the Eastern mediterranean region. Vaccines. 2024. https:\/\/doi.org\/10.3390\/vaccines12080906","journal-title":"Vaccines"},{"issue":"5","key":"11716_CR30","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.10302","volume":"6","author":"E Mostafavi","year":"2023","unstructured":"Mostafavi E, Eybpoosh S, Karamouzian M, Khalili M, Haji-Maghsoudi S, Salehi-Vaziri M, et al. Efficacy and safety of a protein-based SARS-CoV-2 vaccine: a randomized clinical trial. JAMA Netw Open. 2023;6(5):e2310302.","journal-title":"JAMA Netw Open"},{"key":"11716_CR31","doi-asserted-by":"publisher","first-page":"e070464","DOI":"10.1136\/bmj-2023-070464","volume":"382","author":"M Mohraz","year":"2023","unstructured":"Mohraz M, Vahdat K, Ghamari SH, Abbasi-Kangevari M, Ghasemi E, Ghabdian Y, et al. Efficacy and safety of an inactivated virus-particle vaccine for SARS-CoV-2, BIV1-CovIran: randomised, placebo controlled, double blind, multicentre, phase 3 clinical trial. BMJ. 2023;382:e070464.","journal-title":"BMJ"},{"issue":"4","key":"11716_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2025.e42670","volume":"11","author":"HR Shamsollahi","year":"2025","unstructured":"Shamsollahi HR, Younesian S, Nikfarjam A, Nasiri Z, Yunesian M. Effectiveness of mass vaccination for prevention of hospitalization, severe disease and death due to SARS-CoV-2 Omicron Ba.2 variant; a case-population study. Heliyon. 2025. https:\/\/doi.org\/10.1016\/j.heliyon.2025.e42670","journal-title":"Heliyon"},{"issue":"1","key":"11716_CR33","doi-asserted-by":"publisher","DOI":"10.1002\/hsr2.70346","volume":"8","author":"F Hasani","year":"2025","unstructured":"Hasani F, Norouzi Z, Jazi K, Roshandel G, Norouzi A. Comparative analysis of COVID-19 severity and mortality among vaccinated and unvaccinated individuals during the delta variant surge in a tertiary care center: a cohort study. Health Sci Rep. 2025;8(1):e70346.","journal-title":"Health Sci Rep"},{"issue":"3","key":"11716_CR34","first-page":"620","volume":"11","author":"M Seif","year":"2023","unstructured":"Seif M, Sharafi M, Seif MS, Bayati M, Karimi J. Effect of COVID-19 vaccination on survival of Iranian patients: comparison of Cox regression, survival tree and forests. J Health Sci Surveillance Syst. 2023;11(3):620\u201330.","journal-title":"J Health Sci Surveillance Syst"},{"key":"11716_CR35","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/1471-2288-3-28","volume":"3","author":"M Godwin","year":"2003","unstructured":"Godwin M, Ruhland L, Casson I, MacDonald S, Delva D, Birtwhistle R, et al. Pragmatic controlled clinical trials in primary care: the struggle between external and internal validity. BMC Med Res Methodol. 2003;3:28.","journal-title":"BMC Med Res Methodol"},{"key":"11716_CR36","unstructured":"Gartlehner GHR, Nissman D et al. Criteria for Distinguishing Effectiveness From Efficacy Trials in Systematic Reviews. Rockville (MD): Agency for Healthcare Research and Quality (US); 2006 Apr. (Technical Reviews, No. 12.) 1, Introduction. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK44024\/"},{"issue":"2","key":"11716_CR37","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.cmi.2021.10.005","volume":"28","author":"T Fiolet","year":"2022","unstructured":"Fiolet T, Kherabi Y, MacDonald CJ, Ghosn J, Peiffer-Smadja N. Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review. Clin Microbiol Infect. 2022;28(2):202\u201321.","journal-title":"Clin Microbiol Infect"},{"issue":"7","key":"11716_CR38","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1056\/NEJMoa2108891","volume":"385","author":"J Lopez Bernal","year":"2021","unstructured":"Lopez Bernal J, Andrews N, Gower C, Gallagher E, Simmons R, Thelwall S, et al. Effectiveness of covid-19 vaccines against the B.1.617.2 (Delta) variant. N Engl J Med. 2021;385(7):585\u201394.","journal-title":"N Engl J Med"},{"key":"11716_CR39","unstructured":"World Health Organization. Guidance on conducting vaccine effectiveness evaluations in the setting of new SARS-CoV-2 variants. INTERIM GUIDANCE. 22 JULY 2021. Addendum to Evaluation of COVID-19 vaccine effectiveness: Interim guidance. accesible at https:\/\/www.who.int\/publications\/i\/item\/WHO-2019-nCoV-vaccine_effectiveness-variants-2021.1"},{"key":"11716_CR40","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0222-2024","volume":"34","author":"G Zhou","year":"2025","unstructured":"Zhou G, Dael N, Verweij S, Balafas S, Mubarik S, Oude Rengerink K, et al. Effectiveness of COVID-19 vaccines against SARS-CoV-2 infection and severe outcomes in adults: a systematic review and meta-analysis of European studies published up to 22 January 2024. Eur Respir Rev. 2025;34:175.","journal-title":"Eur Respir Rev"},{"issue":"10308","key":"11716_CR41","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1016\/S0140-6736(21)02046-8","volume":"398","author":"PR Krause","year":"2021","unstructured":"Krause PR, Fleming TR, Peto R, Longini IM, Figueroa JP, Sterne JAC, et al. Considerations in boosting COVID-19 vaccine immune responses. Lancet. 2021;398(10308):1377\u201380.","journal-title":"Lancet"},{"issue":"10328","key":"11716_CR42","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/S0140-6736(22)00152-0","volume":"399","author":"DR Feikin","year":"2022","unstructured":"Feikin DR, Higdon MM, Abu-Raddad LJ, Andrews N, Araos R, Goldberg Y, et al. Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression. Lancet. 2022;399(10328):924\u201344.","journal-title":"Lancet"},{"key":"11716_CR43","unstructured":"Hasan SAW. Interim Statement on Booster Doses for COVID-19 Vaccination. Available online: https:\/\/www.who.int\/news\/item\/22-12-2021-interim-statement-on-booster-doses-for-covid-19-vaccination---update-22-december-2021 (accessed on 31 January 2025)."},{"issue":"5","key":"11716_CR44","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/S2213-2600(23)00015-2","volume":"11","author":"N Wu","year":"2023","unstructured":"Wu N, Joyal-Desmarais K, Ribeiro PAB, Vieira AM, Stojanovic J, Sanuade C, et al. Long-term effectiveness of COVID-19 vaccines against infections, hospitalisations, and mortality in adults: findings from a rapid living systematic evidence synthesis and meta-analysis up to December, 2022. Lancet Respir Med. 2023;11(5):439\u201352.","journal-title":"Lancet Respir Med"},{"issue":"5","key":"11716_CR45","doi-asserted-by":"publisher","first-page":"e470","DOI":"10.7861\/clinmed.2021-0225","volume":"21","author":"F Narrainen","year":"2021","unstructured":"Narrainen F, Shakeshaft M, Asad H, Holborow A, Blyth I, Healy B. The protective effect of previous COVID-19 infection in a high-prevalence hospital setting. Clin Med (Lond). 2021;21(5):e470\u20134.","journal-title":"Clin Med (Lond)"},{"key":"11716_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2021.778243","volume":"9","author":"H Ali","year":"2021","unstructured":"Ali H, Alahmad B, Al-Shammari AA, Alterki A, Hammad M, Cherian P, et al. Previous COVID-19 infection and antibody levels after vaccination. Front Public Health. 2021. https:\/\/doi.org\/10.3389\/fpubh.2021.778243","journal-title":"Front Public Health"},{"issue":"42","key":"11716_CR47","doi-asserted-by":"publisher","first-page":"6339","DOI":"10.1016\/j.vaccine.2023.08.069","volume":"41","author":"Y Fu","year":"2023","unstructured":"Fu Y, Wu K, Wang Z, Yang H, Chen Y, Wu L, et al. Effectiveness of various COVID-19 vaccine regimens among 10.4 million patients from the National COVID cohort collaborative during pre-Delta to Omicron periods - United States, 11 December 2020 to 30 June 2022. Vaccine. 2023;41(42):6339\u201349.","journal-title":"Vaccine"},{"issue":"5","key":"11716_CR48","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1017\/S1049023X21000777","volume":"36","author":"M Heidari","year":"2021","unstructured":"Heidari M, Jafari H. Challenges of COVID-19 vaccination in Iran: in the fourth wave of pandemic spread. Prehosp Disaster Med. 2021;36(5):659\u201360.","journal-title":"Prehosp Disaster Med"},{"issue":"26","key":"11716_CR49","doi-asserted-by":"publisher","first-page":"3923","DOI":"10.1016\/j.vaccine.2023.05.022","volume":"41","author":"P Langlete","year":"2023","unstructured":"Langlete P, Tesli M, Veneti L, Starrfelt J, Elstr\u00f8m P, Meijerink H. Estimated vaccine effectiveness against SARS-CoV-2 delta and Omicron infections among health care workers and the general adult population in Norway, August 2021 - January 2022. Vaccine. 2023;41(26):3923\u20139.","journal-title":"Vaccine"},{"key":"11716_CR50","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.ijid.2021.11.009","volume":"114","author":"C Zheng","year":"2022","unstructured":"Zheng C, Shao W, Chen X, Zhang B, Wang G, Zhang W. Real-world effectiveness of COVID-19 vaccines: a literature review and meta-analysis. Int J Infect Dis. 2022;114:252\u201360.","journal-title":"Int J Infect Dis"},{"issue":"5","key":"11716_CR51","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.jinf.2021.12.044","volume":"84","author":"HJ Whitaker","year":"2022","unstructured":"Whitaker HJ, Tsang RSM, Byford R, Andrews NJ, Sherlock J, Sebastian Pillai P, et al. Pfizer-BioNTech and Oxford AstraZeneca COVID-19 vaccine effectiveness and immune response amongst individuals in clinical risk groups. J Infect. 2022;84(5):675\u201383.","journal-title":"J Infect"},{"key":"11716_CR52","doi-asserted-by":"publisher","unstructured":"McKeigue PM, McAllister DA, Bishop J et al. Efficacy of COVID-19 vaccination in individuals designated as clinically extremely vulnerable in Scotland [version 1; peer review: 1 approved with reservations, 1 not approved]. F1000Research 2021, 10:663 (https:\/\/doi.org\/10.12688\/f1000research.53812.1).","DOI":"10.12688\/f1000research.53812.1"},{"issue":"9","key":"11716_CR53","doi-asserted-by":"publisher","first-page":"e28","DOI":"10.1056\/NEJMclde2101987","volume":"384","author":"SR Kadire","year":"2021","unstructured":"Kadire SR, Wachter RM, Lurie N. Delayed second dose versus standard regimen for Covid-19 vaccination. N Engl J Med. 2021;384(9):e28.","journal-title":"N Engl J Med"},{"issue":"10287","key":"11716_CR54","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1016\/S0140-6736(21)00947-8","volume":"397","author":"EJ Haas","year":"2021","unstructured":"Haas EJ, Angulo FJ, McLaughlin JM, Anis E, Singer SR, Khan F, et al. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in israel: an observational study using National surveillance data. Lancet. 2021;397(10287):1819\u201329.","journal-title":"Lancet"},{"issue":"4","key":"11716_CR55","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1097\/EDE.0000000000001366","volume":"32","author":"JA Lewnard","year":"2021","unstructured":"Lewnard JA, Patel MM, Jewell NP, Verani JR, Kobayashi M, Tenforde MW, et al. Theoretical framework for retrospective studies of the effectiveness of SARS-CoV-2 vaccines. Epidemiology. 2021;32(4):508\u201317.","journal-title":"Epidemiology"},{"issue":"6","key":"11716_CR56","first-page":"2060","volume":"45","author":"M Lipsitch","year":"2016","unstructured":"Lipsitch M, Jha A, Simonsen L. Observational studies and the difficult quest for causality: lessons from vaccine effectiveness and impact studies. Int J Epidemiol. 2016;45(6):2060\u201374.","journal-title":"Int J Epidemiol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11716-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11716-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11716-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T12:03:23Z","timestamp":1759838603000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11716-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,7]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11716"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11716-6","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,7]]},"assertion":[{"value":"31 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1245"}}